Advertisement
Novara — A Smarter Way to Access Global Markets
LIVE DESK·Global markets desk

Markets

Elmera posts 30% profit jump as Fortum takeover review continues
EquitiesArticle

Elmera posts 30% profit jump as Fortum takeover review continues

Norwegian energy group Elmera reported a 30% rise in second-quarter adjusted EBIT to NOK 121 million, while its debt fell sharply to NOK 1.04 billion amid an ongoing cash tender offer by Fortum.

20 Aug 2026
Swiss SMI slips as 19 of 20 components fall; Geberit, DocMorris advance on earnings
EquitiesArticle

Swiss SMI slips as 19 of 20 components fall; Geberit, DocMorris advance on earnings

The Swiss blue-chip index was set to open lower, with Geberit the sole gainer after strong half-year results. DocMorris surged 8% on earnings, while BKW dropped 3%. Global yields near multi-decade highs weighed on risk assets.

Complete Genomics appoints Lauren Selig to board ahead of Swiss Rockets deal
EquitiesArticle

Complete Genomics appoints Lauren Selig to board ahead of Swiss Rockets deal

Selig joins as Swiss Rockets AG prepares to acquire the DNA sequencing firm, pending U.S. regulatory clearance. Her appointment reflects the deal's focus on precision healthcare and biotech innovation.

InterCure sets 1-for-5 reverse stock split for Aug. 24, 2026
EquitiesArticle

InterCure sets 1-for-5 reverse stock split for Aug. 24, 2026

The move aims to lift the share price above Nasdaq’s $1 minimum bid requirement. Trading will continue under the same ticker INCR.

Zaptec posts record Q2 revenue as EV charging orders surge 94%
EquitiesArticle

Zaptec posts record Q2 revenue as EV charging orders surge 94%

Norwegian EV charging firm Zaptec reported a 32% revenue increase to 506 million NOK in Q2 2026, while order intake nearly doubled to 894 million NOK. EBITDA rose 57% to 69 million NOK as margins expanded.

Zaptec posts record Q2 2026 revenue, shares rise 0.3%
EquitiesArticle

Zaptec posts record Q2 2026 revenue, shares rise 0.3%

Norwegian EV charging firm Zaptec reported 506 million NOK in revenue, up 32% YoY, while order intake surged 94%. Shares edged up 0.32% to $47.50 in early trading.

Burckhardt Compression plans up to 220 job cuts in restructuring drive
EquitiesArticle

Burckhardt Compression plans up to 220 job cuts in restructuring drive

Swiss compressor maker to slash up to 150 roles in Winterthur and 70 internationally, targeting annual savings of 20 million francs by 2026.

Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook
EquitiesArticle

Straumann posts 7.8% organic revenue growth in H1, confirms 2026 outlook

Zahnimplantatehersteller Straumann reports 2.3% total revenue growth to CHF 1.38 billion in H1, with organic sales up 7.8%. CEO transition announced as Daniellot steps down after seven years.

Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook
EquitiesArticle

Emmi posts 2.2% revenue rise in H1 2026, lifts annual outlook

Swiss dairy group Emmi reports stronger-than-expected first-half growth, with revenue up 2.2% to CHF 2.32bn, while maintaining full-year EBIT and net margin guidance.

KME plans Frankfurt IPO for copper-nickel unit Cunova worth up to $1.2 bln
EquitiesArticle

KME plans Frankfurt IPO for copper-nickel unit Cunova worth up to $1.2 bln

Italian metals group KME has selected Berenberg and UniCredit to lead an IPO for its copper-nickel unit Cunova in Frankfurt, with a potential valuation of €1 billion. Listing could occur in 2026 or 2027.

Geberit lifts H1 sales on volumes, price hikes; shares surge 7%
EquitiesArticle

Geberit lifts H1 sales on volumes, price hikes; shares surge 7%

Swiss sanitary products maker posts 2.8% reported net sales growth in first half, driven by higher volumes and pricing, while maintaining full-year guidance. Shares jump over 7% on strong Q2 beat.

Taiho and Cullinan to present lung cancer drug trial results at 2026 conference
EquitiesArticle

Taiho and Cullinan to present lung cancer drug trial results at 2026 conference

Phase 3 REZILIENT3 trial of Zipalertinib plus chemotherapy met its primary endpoint in EGFR exon 20 insertion mutation-positive NSCLC patients. Results to be showcased at IASLC World Conference.

US stocks mixed pre-market; Moderna surges 100% on cancer therapy data
EquitiesArticle

US stocks mixed pre-market; Moderna surges 100% on cancer therapy data

Moderna jumps 100% in premarket trading after data showed its personalized mRNA cancer vaccine combined with Merck’s Keytruda cut melanoma recurrence. SMI rises 0.36% as Lowe’s cuts guidance, Estee Lauder gains.

WiseTech Global shares plunge 11.5% after ACCC raid
EquitiesArticle

WiseTech Global shares plunge 11.5% after ACCC raid

Logistics software firm faces regulatory scrutiny as Australian watchdog demands documents related to global supply chain services. Shares hit session lows within minutes.

Leroy Seafood lifts wild-catch outlook despite Q2 earnings dip
CommoditiesArticle

Leroy Seafood lifts wild-catch outlook despite Q2 earnings dip

Norway-based seafood producer raises full-year EBIT guidance for wild-catch segment to NOK 400-450 million on higher volumes and pricing, offsetting a 26% drop in Q2 operational EBIT.

EUR/USD breakout tests dollar’s yield-driven support amid Treasury buybacks
ForexArticle

EUR/USD breakout tests dollar’s yield-driven support amid Treasury buybacks

Dollar weakens after U.S. Treasury doubles long-end bond buybacks to $4bn, narrowing yield spreads with Germany. EUR/USD eyes 1.1785 after breaking above 200-day average.

Zaptec posts record Q2 revenue, order intake surges 94%
EquitiesArticle

Zaptec posts record Q2 revenue, order intake surges 94%

Norwegian EV charging firm reports 32% revenue growth and a 97% jump in order backlog. Europe’s top AC charging provider expands production as plug-in vehicle sales rise.

Desert Control sees 500% jump in pilot projects, lifts 2026 revenue target
EquitiesArticle

Desert Control sees 500% jump in pilot projects, lifts 2026 revenue target

The agritech firm raised its full-year revenue guidance to $2 million, citing a surge in Tier 1 pilots and a $56 million potential pipeline. Stock remains near 52-week lows.

Kuaishou Q2 profit steady as stock slides 4% on margin pressure
EquitiesArticle

Kuaishou Q2 profit steady as stock slides 4% on margin pressure

Revenue rose 1.4% year-over-year to 35.5 billion yuan, but gross margin narrowed to 51.6% as costs climbed. Kling AI revenue tripled to over 850 million yuan.